ENTITY
Grifols SA

Grifols SA (GRF SM)

67
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishRoche Holding
18 Oct 2021 06:34

Liquid Universe of European Ordinary and Preferred Shares: October Report

Spreads have generally tightened since mid-September, in line with market gains. Interesting situations are the German liquid shares and Roche.

Share
bearishBiotest AG
20 Sep 2021 18:56

Grifols/Biotest: Preference Shareholders at Disadvantage & Grifols's Leverage

The deal should succeed and there are no grounds for Grifols to offer more than €37/pref. Price is high, with negative implications for Grifols's...

Share
bullishRoche Holding
16 Sep 2021 19:30

Liquid Universe of European Ordinary and Preferred Shares: September Report

Spreads have generally widened during the last four weeks, in line with selling pressure on the markets. Interesting situations are: BMW, Fuchs,...

Share
bullishVolkswagen
23 Aug 2021 12:41

Liquid Universe of European Ordinary and Preferred Shares: August Report

Spreads have generally tightened during the last five weeks, with some notorious exceptions like Roche and Volkswagen. It seems the time to put the...

Share
bearishVolkswagen
16 Jul 2021 15:54

Liquid Universe of European Ordinary and Preferred Shares: July Report

Discounts/Premiums have not followed a clear trend since mid-June. Interesting situations are Henkel, BMW, and SSAB, in my view.

Share
x